$KTTA Cashflow Statement | Understand Stock

$KTTA

$0.40 -$0.00 (0.65%) Close

$KTTA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss from continuing operations
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Amortization expense
Stock-based compensation
Shares issued for services
Bad debt expense
Non-cash lease expense
Change in fair value of warrant liabilities
Gain on sale of assets
Impairment expense
Realized foreign currency translation loss from dissolution of subsidiaries
Change in fair value of derivative warrant liability
Loss on asset disposal

Changes in operating assets and liabilities:
Prepaid expenses
Other assets
Other current assets
Accounts payable and accrued liabilities
Lease liabilities
Net cash used in operating activities
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Proceeds from the sale of equipment
Acquisition of business, net of cash acquired
Acquisitions of intangible assets
Net cash provided by investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Cash proceeds from sale of 4,800,000 Units
Proceeds from sale of September 2024 Offering warrants
Payments on financed director and officer insurance
Cash proceeds received from exercise of warrants
Cash proceeds from sale of units in IPO, net of fees and costs
Sale of common stock and warrants, net of fees and costs
Proceeds from issuance of common stock from the exercise of pre-funded warrants, net
Proceeds from May 2025 public offering of common stock, net
Proceeds from December 2025 public offering of common stock, net
Issuance of common stock from the exercise of warrants, net
Payment of offering costs
Repurchase of shares in litigation settlement
Payment of offering costs in connection with September 2024 Offering warrants
Note payable proceeds
Principal payments on note payable
Repurchase of common stock
Shares repurchased in litigation settlement
Net cash provided by (used in) financing activities
Proceeds from September 2024 offering of pre-funded and common warrants, net
Net cash provided by financing activities
Effect of foreign currency translation on cash

Effect of foreign currency translation on cash
Net cash used in operating activities of discontinued operations
Net cash provided by investing activities of discontinued operations
Net cash provided by (used in) financing activities of discontinued operations
NET CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
Cash, cash equivalents, and restricted cash - Beginning of period
Cash, cash equivalents, and restricted cash - End of period
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash
Total cash, cash equivalents and restricted cash
Supplemental disclosure of cash flow information:
Equity purchase consideration for acquired business
Equity purchase consideration for acquired intangible assets
Lease liabilities arising from obtaining right-of-use assets
Initial recording of warrant liabilities
Amount due from sale of assets
Deemed dividend – warrant modification
Cash paid for interest

Supplemental disclosures of non-cash activity:
Initial recording of warrant liabilities
Dividend - warrant modification

Comments